Monoclonal antibody production services: choosing a monoclonal antibody service and the monoclonal antibody companies or a monoclonal antibodies manufacturer behind it by scale and purity, what hybridoma antibody production and a hybridoma monoclonal antibody route commit you to, how monoclonal antibodies production differs between a mouse monoclonal antibody, mouse monoclonal antibodies generally and a rabbit monoclonal antibody service or rabbit monoclonal antibody production, where rabbit antibodies suit a target mice tolerate, and what must accompany every batch

Matching route to purpose

1. Transient expression for speed and small scale. Transfecting cells for a short production run gives material in weeks without developing a line. It suits research quantities, candidate comparison and early studies, and the cost per unit rises steeply as quantity grows.
2. Stable line for quantity and repeatability. Developing a stable line costs months and pays back at scale and where every batch must match. Programmes that will need material repeatedly should start the line early, because it sits on the critical path of everything that follows.
3. Purification depth follows the use. Affinity capture alone suits many research uses. Polishing to remove aggregate, and additional steps to remove host cell protein and DNA, are needed where the material goes into cells, into animals or toward a regulated application. Each step costs yield as well as money.
4. Endotoxin, aggregate and the formulation. Specify an endotoxin limit for anything touching cells or animals, an aggregate limit, and the final buffer and concentration. Antibody delivered in the provider's default formulation frequently needs an exchange the customer then performs badly.
5. Documentation matched to the destination. Research material needs a certificate of analysis. Material heading toward a regulated application needs manufacturing records, a traceable cell bank and a quality system, and retrofitting those onto a research batch is not possible.

What should accompany each batch

Identity confirmation, concentration by a stated method, purity with the method and the trace, aggregate content, endotoxin where relevant, and the cell bank and process reference. Ask for the traces rather than a summary certificate.

Retain an aliquot of each batch under your own control. Without a retained reference, a question about whether a new batch differs cannot be answered.

Species, isotype and downstream compatibility

The host species and isotype determine which secondary reagents and which purification chemistry apply, and they can constrain multiplexing later. Fix them from the intended applications rather than from what the provider produces most easily.

Where the antibody may be humanised or engineered later, having the variable region sequences in hand makes that a straightforward project instead of a repeat of the discovery work.

Common questions

Transient or stable expression for monoclonal antibody production?

Transient for speed and research quantities, since it needs no line development. Stable for larger quantities and batch-to-batch consistency, accepting several months of development first.

How pure does the antibody need to be?

Affinity capture alone suits many research uses. Cell-based work, animal work and anything heading toward a regulated application need polishing and host cell protein and DNA removal, each costing yield.

What should the certificate of analysis show?

Identity, concentration and purity each by a stated method with the trace, aggregate content, and endotoxin where the material touches cells or animals, against limits agreed before manufacture.

Can research material be used later for a regulated application?

Generally not. Regulated use requires manufacturing records, a traceable cell bank and a quality system that cannot be applied retrospectively to a research batch.

Browse by service class

• Compare Gene synthesis on advertised prices